Anti-PD-1 Therapy in Combination With Platinum Chemotherapy for Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
Phase of Trial: Phase I/II
Latest Information Update: 14 Jun 2018
At a glance
- Drugs Pembrolizumab (Primary) ; Carboplatin
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 06 Apr 2017 Status changed from not yet recruiting to recruiting.
- 29 Mar 2017 Planned initiation date changed from 1 Feb 2017 to 21 Apr 2017.